$BLTE SEC Filings

Filed On	Filing
19 Oct 2026	FORM 6-K
05 Oct 2026	Form 4: Scholl Hendrik Peter, Chief Medical Officer Sold 500 shares ($82.7K)
01 Oct 2026	144
09 Sep 2026	Form 4: Lin Yu-Hsin, Director Sold 74,435 shares ($14M) · Sold 26,000 shares ($5.11M)
09 Sep 2026	Form 4: Chuang Hao-Yuan, Director Sold 49,433 shares ($9.28M) · Sold 17,962 shares ($3.53M)
08 Sep 2026	FORM 6-K
14 Aug 2026	Form 4: Chuang Hao-Yuan, Director Sold 367 shares ($66.2K)
14 Aug 2026	Form 4: Lin Yu-Hsin, Director Sold 365 shares ($65.8K)
13 Aug 2026	FORM 6-K
12 Aug 2026	144
12 Aug 2026	144
11 Aug 2026	FORM 6-K
22 Jun 2026	Form 4: Scholl Hendrik Peter, Chief Medical Officer Sold 10,000 shares ($1.45M)
18 Jun 2026	144
17 Jun 2026	Form 4: Scholl Hendrik Peter, Chief Medical Officer Sold 10,000 shares ($1.41M)
16 Jun 2026	144
15 Jun 2026	FORM 6-K
20 May 2026	FORM 6-K
14 May 2026	SCHEDULE 13G/A
08 May 2026	Form 4: Mata Nathan L., Chief Scientific Officer Sold 666 shares ($102K)

Comments